c-Myc, which is associated with the malignant progression of cancer [8], binds to the human telomerase reverse transcriptase (hTERT) promoter and positively regulates hTERT to induce telomerase reactivation or to increase telomerase activity [9, 10], each of which leads to telomere lengthening and cell proliferation. Here, MYC is linked to cancer.